Loading…

Trisenox induces cytotoxicity through phosphorylation of mitogen‐activated protein kinase molecules in acute leukemia cells

Trisenox (TX) has been used successfully for the treatment of acute promyelocytic leukemia (APL) patients. TX‐induced cytotoxicity in APL cells remains poorly understood. In this study, we investigated the molecular mechanism of TX cytotoxicity using APL cell lines. We assessed TX toxicity by quanti...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biochemical and molecular toxicology 2018-10, Vol.32 (10), p.e22207-N/A
Main Authors: Kumar, Sanjay, Farah, Ibrahim O., Tchounwou, Paul B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Trisenox (TX) has been used successfully for the treatment of acute promyelocytic leukemia (APL) patients. TX‐induced cytotoxicity in APL cells remains poorly understood. In this study, we investigated the molecular mechanism of TX cytotoxicity using APL cell lines. We assessed TX toxicity by quantitatively measuring lactate dehydrogenase levels. Inhibition of cell cycle progression was assessed by confocal microscopy of Ki‐67 expression. Apoptosis was evaluated by Western blot analysis of apoptotic proteins expression, immunocytochemistry, and confocal imaging of annexin V and propidium iodide. Mitogen‐activated protein kinase (MAPK) signaling cascade was analyzed by Western blot analysis and inhibitor‐based experiments with APL cells. We found that TX‐induced cytotoxicity inhibited APL cell cycle progression. TX also induced significant (P 
ISSN:1095-6670
1099-0461
DOI:10.1002/jbt.22207